NexImmune is a rapidly growing leader in the emerging field of antigen-directed immunotherapies. We are developing a novel technology platform with broad ...
Investors · Overview · Press Releases · Events and Presentations · Financials and Filings · Stock Information · Corporate Governance · Email Alerts · Contact.
People also ask
Is NexImmune legit?
Who is the CEO of NexImmune?
Will Nexi stock go up?
What does NexImmune Inc. do?
We welcome you to the 2023 Annual Meeting of Stockholders of NexImmune,. Inc ... Investor Relations at CRubin@neximmune.com. 8. Any recording of the Annual ...
Get the latest insights on NexImmune, Inc. Common Stock (NEXI) with press releases and corporate news to help you in your trading and investing decisions.
Mar 2, 2024 · NexImmune is a publicly traded, clinical stage biotechnology company developing unique approaches to T cell immunotherapies based on its ...
Missing: investor relations
Aug 10, 2023 · Investors and Media: Chad Rubin, SVP Corporate Affairs and Investor Relations NexImmune, Inc. crubin@neximmune.com. NEXIMMUNE, INC. BALANCE ...
... investor for the issuance and sale of an aggregate of ... NexImmune Announces Presentations at The Society for Immunotherapy of Cancer's 38th Annual Meeting.